Related Experiment Video
Updated: May 4, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin
M Dolenc-Voljč1, V Jurčić2, A Hočevar3
1Department of Dermatovenereology, University Medical Centre Ljubljana, Slovenia ; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Abstract:
Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, intravenous immunoglobulin (IVIg) appears to be the therapy of choice for scleromyxedema. Treatment experiences in atypical manifestations with mucinous nodules are limited to sporadic reports. We report the case of male patient with atypical scleromyxedema without underlying paraproteinemia, presenting with generalized papular and sclerodermoid skin eruption and multiple nodular mucinous lesions on the fingers and face as well as on the eyelids, and associated systemic symptoms. Complete regression of all cutaneous lesions and extracutaneous symptoms with sustained remission was achieved by combined treatment with thalidomide and IVIg.
Related Concept Videos
Graves Disease II: Pathophysiology
Graves' Disease I: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Nephrotic Syndrome II : Assessment and Medical Management